These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20851231)

  • 1. A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.
    Meendering JR; Torgrimson BN; Miller NP; Kaplan PF; Minson CT
    Contraception; 2010 Oct; 82(4):366-72. PubMed ID: 20851231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol.
    Torgrimson BN; Meendering JR; Kaplan PF; Minson CT
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2874-80. PubMed ID: 17277029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women.
    Meendering JR; Torgrimson BN; Miller NP; Kaplan PF; Minson CT
    Contraception; 2009 Jan; 79(1):41-9. PubMed ID: 19041440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
    Anttila L; Kunz M; Marr J
    Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of drospirenone (3 mg) with ethinyl estradiol (30 mcg) containing pills on ovarian blood flows in women with polycystic ovary syndrome: a case controlled study.
    Okyay E; Gode F; Acet F; Bodur T; Cagliyan E; Sahan C; Posaci C; Gulekli B
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():93-9. PubMed ID: 25063905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age.
    de Morais TL; Giribela C; Nisenbaum MG; Guerra G; Mello N; Baracat E; Consolim-Colombo FM
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():113-7. PubMed ID: 25268778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder.
    Marr J; Heinemann K; Kunz M; Rapkin A
    Int J Gynaecol Obstet; 2011 May; 113(2):103-7. PubMed ID: 21338987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
    Douxfils J; Klipping C; Duijkers I; Kinet V; Mawet M; Maillard C; Jost M; Rosing J; Foidart JM
    Contraception; 2020 Dec; 102(6):396-402. PubMed ID: 32956694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.
    Kelly S; Davies E; Fearns S; McKinnon C; Carter R; Gerlinger C; Smithers A
    Clin Drug Investig; 2010; 30(5):325-36. PubMed ID: 20384388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of two contraceptives containing drospirenone on blood pressure in normotensive women: a randomized-controlled trial.
    de Nadai MN; Nobre F; Ferriani RA; Vieira CS
    Blood Press Monit; 2015 Dec; 20(6):310-5. PubMed ID: 26154851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women.
    Suthipongse W; Taneepanichskul S
    Contraception; 2004 Jan; 69(1):23-6. PubMed ID: 14720615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study.
    Cagnacci A; Ferrari S; Napolitano A; Piacenti I; Arangino S; Volpe A
    Contraception; 2013 Sep; 88(3):413-7. PubMed ID: 23312932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium.
    Franceschini SA; Vieira CS; Martins WP; França JB; Ferriani RA
    Contraception; 2013 Jun; 87(6):766-72. PubMed ID: 23102798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
    Yildizhan R; Yildizhan B; Adali E; Yoruk P; Birol F; Suer N
    Arch Gynecol Obstet; 2009 Aug; 280(2):255-61. PubMed ID: 19125264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
    Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
    Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM; Fauser BC
    Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.